American Epilepsy Society: Epilepsy Study Consortium Mini-Grant

American Epilepsy Society: Epilepsy Study Consortium Mini-Grant

Status: ACTIVE
Funder: American Epilepsy Society
Amount: Up to US $22,000
Last Updated: December 04, 2025

Summary

The American Epilepsy Society offers the Epilepsy Study Consortium Mini-Grant, providing up to $22,000 for epilepsy fellows to conduct mentored research on anti-epileptic drug therapy during their fellowship. This grant supports projects focused on clinical, translational, or basic science methods and allows for six months to one year of funding. It aims to enhance mentorship and training for fellows, facilitating their participation in significant epilepsy research and related conferences.

Overview

Epilepsy Study Consortium Mini-Grant The Epilepsy Study Consortium is sponsoring a mini-grant of up to $22,000 for epilepsy fellows to undertake a mentored research project on anti-epileptic drug therapy during their fellowship training and to attend the AES Annual Meeting. The award does not require past experience with research or a specific percent protected time for research but instead focuses on the mentorship and training experience for the fellow. Applicants may request funding periods of six months to one year. The Epilepsy Study Consortium mini-grant is open to epilepsy fellows seeking to undertake a mentored research project on anti-epileptic drug therapy during their fellowship training. The project budget can be up to a total of $22,000, with up to $20,000 for direct research costs and up to $2,000 for travel to the AES Annual Meeting. In addition, the ESC will work directly with the awardee to provide funding for the awardee to attend either the Antiepileptic Drug and Device Trials Symposium (AEDD) or the Epilepsy Foundation Pipeline meeting depending on the award year. The award does not require past experience with research or a specific percent protected time for research but instead focuses on the mentorship and training experience for the fellow. Applicants may request funding periods of six months to one year. Research must focus on anti-epileptic drug therapy, either with clinical, translational, or basic science methods. Funds may be used to support a limited research project or for the collection of preliminary data leading to a larger research effort. Examples of appropriate projects include, but are not limited to, prospective or retrospective studies on treatment outcomes or adverse events in specific populations, or studies enabling randomized controlled trials (such as evaluations of new therapeutic trial methodology).

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.